Apple plans a smartwatch refresh with Apple Watch Series 11, Watch Ultra 3, and Watch SE 3 timed to the September 9 event. The Series 11 will keep Series 10's flat-edged design in 42mm and 46mm sizes and retain an LTPO display while gaining an S11 SoC with largely the same architecture. A new blood-pressure monitoring capability will aim to detect hypertension signs and alert the wearer rather than supplying systolic/diastolic readings, though its arrival on Series 11 is uncertain. Apple may adopt MediaTek modems and bring 5G RedCap support to future watch models.
The Apple Watch Series 11 will not undergo any major design changes over the Series 10. Both 42mm and 46mm variants are expected to retain the same flat-edged design with a curved glass housing an LTPO panel on top. However, there will be iterative upgrades under the hood. The Apple Watch Series 11 will be powered by an S11 SoC, albeit with the same architecture as the previous generations.
The upcoming smartwatches will reportedly debut a new blood pressure monitoring feature. But instead of providing systolic and diastolic readings, it said to be designed to look out for possible signs of hypertension and alert the wearer if any such symptom is detected. If these leaks are accurate, it would be a first for Apple's standard smartwatch lineup. However, there is uncertainty over its arrival with the Series Watch 11, and there is a chance it could get deferred to future models.
#apple-watch-series-11 #blood-pressure-monitoring #mediatek-modem--5g-redcap #apple-smartwatch-lineup
Collection
[
|
...
]